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Abstract
Bisphenol A (BPA), a known endocrine disruptor, is a food contaminant suspected of being a contributing factor to the present-
day increase in obesity, diabetes, and cardiovascular disease. This issue is of increasing interest in the field of diabetes research and
has become a matter of concern for regulatory agencies and food industries. Recently, the number of studies involving BPA has
increased exponentially, but there are still many gaps in the knowledge of the relationship between actual BPA exposure and
cardiometabolic risk and of the modalities of food intake exposure, all of which prevents sound judgments concerning the risks to
human health. This review focuses on the association between human exposure to BPA and obesity, thyroid function, diabetes,
insulin resistance, metabolic syndrome, cardiovascular diseases, and BPA content in food. Many cross-sectional studies support,
sometimes contradictorily, an adverse effect of BPA exposure on obesity, diabetes, and cardiovascular diseases. Few prospective
studies support an adverse effect of BPA exposure on such pathologies. Moreover, no intervention studies have been conducted
to evaluate the causality of such associations. This is mainly due to lack of an appropriate database of BPA content in foods, thus
hindering any estimation of the usual dietary BPA intake.
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Introduction
The prevalence of obesity, diabetes, and cardiovascular disease
(CVD) has reached epidemic proportions worldwide and is
continuing to increase. Data from different regions throughout
the world suggest that more than 1 adult in every 5 adults has
metabolic syndrome, a predisposition of the above-mentioned
diseases.1,2 Although the pathogenesis is multifactorial, excess
visceral fat and defective insulin action are the cornerstones to
the disease. The ‘‘big two’’ causes are considered to be over-
eating and a sedentary lifestyle, so most research and therapeu-
tic effort has been focused on the control of food intake, the
increment of energy expenditure, and improvement in insulin
action. The failure of these efforts to slow down the increasing
rate of the epidemic has led to the most authoritative research-
ers turning their attention to alternative hypotheses.3 Indeed,
the epidemic has been associated with a worldwide increment
in exposure to environmental chemical pollutants, which are
collectively termed endocrine disruptors (EDs) that interfere
with the production, release, transport, metabolism, binding
action, and elimination of natural hormones regulating home-
ostasis and development. Also food and beverages have chan-
ged within this same time frame, having become susceptible to
ED contamination through processing and packaging and being
subsequently shared across the globe. One of the best studied
and most prevalent EDs is bisphenol A (BPA).
Like other EDs, BPA acts by mimicking the action of estra-
diol. The exposure to BPA in inappropriate concentrations, and
during an improper time window, can affect multiple organ
system development and function, including control of energy
balance and glucose homeostasis.
In the 1950s, polymer chemists discovered that BPA mole-
cules could be polymerized to make polycarbonate plastic, and
it soon became a basic compound in the manufacture of the
resin lining food and beverage cans and of the polycarbonate
used in food and beverage storage containers. The leaching of
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BPA out of such products is increased by heating, contact with
alkaline/acid substances, and repeated use and exposure to
microwaves. Indeed, contact with food is thought to be a major
contributor to the mean values of 2 to 4 ng mL1 of unconju-
gated BPA detected in adult and foetal serum.4,5 Currently, a
daily dose of 50 mg kg1 d1 is considered ‘‘safe’’ for human
consumption,6 but recent findings suggest that the current lev-
els of human exposure to BPA exceed the daily dose. Bisphenol
A is highly glucuronidated in the liver and is primarily excreted
into the bile. However, unconjugated (bioactive) BPA can be
found in the blood and, in its glucuronidated form, in urine.5
Unconjugated BPA circulating in blood indicates an internal
exposure to the compound, as does its presence in urine, but in
this latter case it also suggests a failure of first-pass conjugation
and removal or deconjugation. Furthermore, age, sex, liver
function, and physiological status (eg, pregnancy) could influ-
ence BPA metabolism. Being lipophilic, BPA can also be
stored in adipose tissue. In animal models, the tissue/serum
concentration ratios range from 0.7 in liver to 5 in adipose
tissue, reflecting differences in tissue perfusion, composition,
and metabolic capacity. One study detected unconjugated BPA
accumulation in half the studied women.7
Bisphenol A endocrine disruption is relevant both in early-
life than in life-time, interfering with the production, release,
transport, metabolism, binding, action, or elimination of natu-
ral hormones, producing the so called ‘‘diabesity phenotype.’’
Given the mounting of so much evidence on the effect of
BPA on human health, there is now harsh debate among scien-
tists, industry, and regulatory agencies on whether BPA should
be banned from use in food packaging.8 In March 2010, Canada
banned BPA from plastic baby bottles and formulas and in
September declared it as a toxic substance harmful to health
and environment. In April 2010, Denmark was the first Eur-
opean country to ban BPA from materials in contact with food
for children older than 0 to 3 years. In November 2010, a joint
World Health Organization and Food and Agriculture Organi-
zation (FAO) panel stated that it would be ‘‘premature to con-
clude that these evaluations provide a realistic estimate of the
human health risk.’’ However, in January 2011, the European
Commission (EC) prohibited the use of BPA for the manufac-
ture of polycarbonate infant feeding bottles. In 2011, the
French Agency for Food, Environmental and Occupational
Health & Safety rated the BPA relationship with diabetes and
CVD in humans as ‘‘suspected,’’ and in the animal rated the
effects on lipid and glucose metabolism ‘‘confirmed’’ and ‘‘con-
troversial,’’ respectively. In 2014, the European Food Safety
Authority (EFSA) launched 2 Web-based public consultations
calling for scientific opinion on public health risks in relation to
BPA presence; however, the results remained inconclusive.
The purpose of this manuscript is to review the available
knowledge of epidemiologic evidence on BPA exposure and
obesity, diabetes, and CVD. However, the review of the state of
the art reveals that all evidence has been produced relating
single measurements of urinary, and rarely plasma, BPA con-
centrations to clinical end points, but the quantification of BPA
intake is still far from being possible due to the large gaps in the
present-day knowledge. We also explored this issue by analyz-
ing the information available on BPA amounts in foods.
Human BPA Exposure and Obesity
The prevalence of obesity has increased steadily over the last 5
decades, reaching epidemic proportions in both developed and
developing countries.9 Furthermore, overweight and obesity
are major contributors to several noncommunicable diseases
such as metabolic syndrome, type 2 diabetes mellitus, coronary
heart disease, stroke, some forms of cancer, and serious social
and psychological sequels. The commonly adduced causes of
obesity, for example, behavioural factors like excessive food
intake associated with erroneous food habits, sedentary life-
style, and genetic predisposition, do not completely explain the
increment in obesity prevalence. For this reason, there is strong
interest in researching obesity pathogenesis, looking for new
possible causes, since the challenge to effectively treat obesity
is still open. In 2002, Baillie-Hamilton suggested, for the first
time, a potential role of chemical toxins in the etiology of
obesity by showing that the present obesity epidemic has coin-
cided with the marked increment in industrial chemicals in the
environment over the past 40 years.10 Following the proposal
of the Baillie-Hamilton hypothesis, several studies investigated
the effect of environmental chemical exposure on nutritional
status. This led to the very strong suspicion that EDs could
induce obesity.11,12 Indeed, EDs can interfere with normal
endocrine system functioning by affecting the endocrine appa-
ratus and, consequently, the serum levels of hormones that
regulate several human metabolism pathways. These com-
pounds have been termed ‘‘obesogens,’’ based on the idea that
they can downregulate lipid metabolism and adipogenesis.
On considering the ED compounds, it is to be noted that
there is a growing evidence that BPA can act as an obesogen
environmental agent, interfering with physiological weight
control patterns. It seems to downregulate adipose tissue meta-
bolism, endocrine hormone systems, and the central hypotha-
lamic–pituitary–adrenal axis.13,14 Bisphenol A may play a role
in the development of obesity not only when exposure occurs
after birth but also when it occurs ‘‘in utero’’. Specifically, it
has been hypothesized that the obesogenic effect of BPA may
be modulated by the availability of methyl donors (eg, folates)
for DNA methylation, this could mean that the programming of
adipogenesis, appetite, and energy metabolism may be perma-
nently damaged and, consequently, increase risk in later life
obesity.15 The epigenetic effects of BPA exposure during
development could interfere with complex differentiating
endocrine signalling pathways and cause adverse consequences
later in life, leading to the concept of ‘‘developmental origins
of adult disease.’’16
Most of the studies concerning the relationship between
BPA and obesity have been conducted in vitro or in vivo on
animal models17,18 and present conflicting results most likely
due to the wide range of BPA doses applied.
On adipocytes, in vitro studies have shown disruptive
effects of BPA on normal adipocyte development as well as
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on the homeostatic control of adipogenesis and early energy
balance.19,20 Specifically, it has been observed that low con-
centrations of BPA induce lipid accumulation mediated by the
production of reactive oxygen species in the mitochondria of
HepG2 cells.21 Moreover, BPA seems to promote adipogen-
esis, stimulating glucocorticoid receptors in the 3 T3-L1 Cell
Line (mouse fibroblasts that can differentiate into adipocytes)
and, in combination with insulin, promoting adipocyte forma-
tion.22,23 Recently, BPA effects on human adipocytes, taken
from breast, subcutaneous, and visceral adipose tissues, were
investigated on more than 20 participants. The authors reported
that BPA between 1 and 10 nmol/L concentrations interfered
with adipocyte metabolism by inhibiting adiponectin release
and stimulating the release of 2 inflammatory cytokines, inter-
leukin (IL-6) and tumor necrosis factor a (TNF-a), showing a
‘U’ shaped dose–response curve and suggesting that BPA can
also act at low dosage.24 Adiponectin is one of the most abun-
dant circulating adipokines, exerting an effect on glucose and
lipid metabolism and modulating insulin sensitivity by stimu-
lating glucose utilization and fatty acid oxidation.25 Moreover,
it also has an anti-inflammatory activity, which together with
the effect on the proinflammatory cytokines TNF-a and IL-6,
may be the link between several noncommunicable diseases
(CVD and type 2 diabetes mellitus) and BPA exposure.24,26
In vivo studies on animal models resulted in controversial
results on the effect of BPA accumulation in adipose tissue,
suggesting that the magnitude of the effect depends on the
timing of exposure and dose; Nunez et al27 showed that, in rats,
high doses of BPA for 15 days led to a reduction in body weight
and lower feeding efficiency, while Seidlova-Wuttke et al28
found that feeding BPA to rats for 3 months did not alter the
body weight, fat depots, or triglyceride levels. During prenatal
and neonatal periods, it was demonstrated that low doses of
BPA, in the human exposure range, in both mice and rats
resulted in increased body weight of the offspring, particularly
the females.29,30
From an epidemiological point of view, there are several
published studies primarily designed to assess the association
between BPA exposure and obesity. Most use a cross-sectional
design,31-34 in children, adolescents, and adults. On the con-
trary, there are very few prospective cohort studies that have
examined early-life BPA exposure effects, and these report
contradictory findings, and only one study has investigated the
effect of weight loss on BPA exposure.35
Cross-sectional studies in children and adolescents. The association
between BPA exposure and nutritional status was explored in
259 Chinese school children (older than 8-15 years).36 The
authors found that high urine BPA concentration and a daily
intake estimate of BPA were significantly associated with an
increment in body mass index (BMI) in all the participants.
Interestingly, they estimated a geometric mean daily intake
of 8.2 ng kg1 day BPA, much lower than the tolerable daily
intake of 50 mg kg1 day recommended by EFSA in 2007.
These findings reinforce the concept that not only hormones
and neurotransmitters, but also endocrine disrupting
substances, exert effects at very low exposure levels. Similarly,
in 1326 Chinese students (older than 4-12 years), high urine
BPA levels were associated with overweight, but only among
female students older than 9-12 years (most likely in pubertal
developmental stages)37; this confirms findings in experimen-
tal animal studies where exposure to high BPA levels led to
weight gain in females but not in males.29 The association
between BPA exposure and obesity was also examined in the
United States on 2200 children older than 6-18 years who
participated in the National Health and Nutrition Examination
Survey (NHANES) in 3 study cycles, 2003–2004, 2005–2006,
and 2007–2008, analyzing gender and race/ethnicity sepa-
rately. The authors found a positive association between
increasing levels of urinary BPA and obesity, independent of
age, sex, race/ethnicity, and other social and life style variables
like education and physical activity level. Children in the high-
est quartile of BPA (>5.4 ng mL1) had a multivariable odds
ratio for obesity of 2.55.38 These results confirmed the conclu-
sion of the study previously conducted on 6- to 19-year-olds
recruited in the same nationally representative survey.32 More-
over, Wells et al39 observed a significant positive association
between BPA exposure and waist-to-hip ratio, suggesting a
relation with central obesity that is a better overall predictor
of cardiometabolic risk, particularly among normal weight or
overweight children.40,41
Cross-sectional studies in adults. In 3390 Chinese adults older than
40 years and older, a positive and significant association
between urinary BPA concentration and the prevalence of gen-
eralized obesity, abdominal obesity, and insulin resistance has
been reported. The BPA concentration was higher in partici-
pants with a higher BMI than in those with lower BMI.33 Sim-
ilar results were also found in a contemporary general
population sample of US adults. The BPA exposure appeared
to be associated to obesity independently of confounding fac-
tors including age, education, smoking, alcohol intake, physi-
cal activity, and other factors, in both genders and in all major
racial/ethnic groups. Interestingly, as occurs in children and
adolescents, also in adults BPA exposure is associated not only
with BMI but also with waist circumference. Among the 2104
adults recruited, waist circumference was found to be signifi-
cantly higher in those with urinary BPA concentrations in the
highest tertile compared to those in the lowest tertile.42 Waist
circumference is a strong indicator of obesity and is signifi-
cantly associated with the risk of future cardiovascular events
in healthy men and women and with all-cause mortality43 in
middle-aged men and women.44 These findings are corrobo-
rated by the results of a cross-sectional study conducted on
1030 Korean adults, in which a positive association between
urinary BPA concentrations and BMI, body fat and waist cir-
cumference was found. Waist circumference was higher among
participants with urinary BPA concentrations in the highest
quartile compared to those with urinary BPA concentrations
in the first and second quartile.45 Recently, the association of
BPA serum level and fat mass, fat distribution and circulating
levels of adiponectin, leptin, and ghrelin was explored in 890
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men and women older than 70, showing that BPA was posi-
tively associated with adiponectin and leptin, negatively with
ghrelin, and unrelated to adipose tissue measurements.46 The
relationship between BPA and ghrelin was stronger in women
than in men. Our previous data indicated that ghrelin concen-
tration in the elderly patients, both basal and after meal sup-
pression, is unrelated to fat mass but is negatively correlated
with fat free mass after statistically adjusting for androgen
levels.47 The effect of BPA on ghrelin plasma levels needs to
be evaluated both at the basal level and after meal suppression,
because ghrelin’s effect on hunger and satiety depends not only
on its basal level but also on its post prandial level and, possi-
bly, the worsening anorexia of aging. The results on circulating
levels of adiponectin and BPA confirm the findings obtained in
the cellular model24 and support the hypothesis that BPA may
interfere with adipocyte metabolism and the hormonal control
of hunger and satiety.
Prospective cohort studies in children and adolescents. In a Spanish
study, Valvi et al48 examined the effects of prenatal BPA expo-
sure on postnatal growth and obesity on 402 pregnant mothers
and their children, measuring BPA concentrations in the first
and third trimesters of pregnancy from mothers and during the
rapid child growth of the first 6 months of life. Bisphenol A was
not associated with obesity-related outcomes at earlier ages,
but at 4 years both waist circumference and BMI were posi-
tively related to BPA exposure. Similarly, Harley et al49 eval-
uated the association of urinary BPA concentrations with BMI,
central obesity, and body fat of 402 pregnant mothers and their
children up to 9 years, and participants recruited in the Salinas
Valley, California. They found that prenatal urinary BPA con-
centrations were associated with decreased BMI and body fat at
9 years in girls, partially confirming the results of Nunez et al27
in the animal model. Urinary BPA concentrations at 5 years
were not associated with any anthropometric parameters at 5 or
9 years, whereas BPA concentrations at 9 years were positively
associated with BMI, waist circumference, fat mass, and over-
weight/obesity at 9 years in boys and girls confirming other
cross-sectional studies.49 These results suggest that the duration
of BPA exposure may be an important determinant in its effect
on human nutritional status. Finally, in 297 mother–child pairs
recruited in the Cincinnati area, the urinary BPA concentrations
of the pregnant women were measured during the second and
third trimesters and in their children at 1, 2, and 5 years. The
BPA exposures were not associated with increased BMI at 2 to 5
years of age whereas higher early childhood BPA exposures
were associated with accelerated growth during this period.50
Prospective cohort studies in adults. Longitudinal studies covering
the time range from ‘‘in utero’’ exposure to adulthood are not
yet available as the first prospective cohort studies started only
in 1999. However, one study involving BPA exposure followed
the effects of significant changes in food intake on 151 obese
participants sampled in Belgium and carried out a follow-up
assessment of the effects of significant changes in food intake
over a period of 1 year. The time course of the urinary BPA
levels throughout the year of dietary treatment for weight loss
was assessed and compared with lean participants. The authors
did not find any significant correlation of the urinary BPA
levels and BMI or any differences within the obese individuals
themselves during the weight loss program at 3, 6, and 12
months, independently of the strategy applied (dietary planning
and lifestyle counselling vs bariatric surgery) for weight loss.35
In conclusion, cross-sectional human studies in children,
adolescents, and adults suggest that urinary BPA concentra-
tions are associated with increased BMI, body fat, and central
obesity, but these findings could result from confounding or
reverse causation because diet is an important source of BPA
exposure and obesity is linked to uncorrected dietary patterns,
for both quality and quantity of foods. Prospective studies have
reported contrasting results and fail to shed light on any pos-
sible link between early exposure and the risk of obesity in
adulthood because, currently, the follow-up period is too short.
Furthermore, more information about exposure sources is
needed to evaluate BPA exposure, not only by urinary excre-
tion measurements but also by food intake assessment. Nutri-
tional knowledge would allow a better understanding of both
BPA metabolism (potentially different in obese patients) and
BPA intake (certainly higher in obese patients). The assessment
of BPA dietary intake is a key element to the creation of oppor-
tunities to reduce BPA exposure.
Human BPA Exposure and Thyroid Hormones
Thyroid hormones regulate energy homeostasis by acting on
both peripheral tissues and the central nervous system.51 Overt
hypothyroidism is associated with decreased resting energy
expenditure (REE) and weight gain, while hyperthyroidism is
associated with increased REE and weight loss. Recently, Spa-
dafranca et al52 did not find any association between REE and
Thyroid-stimulating hormone (TSH) in euthyroid participants,
confirming results obtained in severely obese patients where
REE was not associated with TSH in the presence of euthyr-
oidism.53 These results taken together suggest that only an
increment or decrement in thyroid hormones beyond the phy-
siological range can affect REE.
It has been supposed that BPA influences thyroid hormone
metabolism, acting either as an agonist or antagonist on the
thyroid hormone receptor.54 In the perinatal period, BPA-
exposed rats had elevated T4 levels during development, and
upregulation of a thyroid hormone-responsive gene in the
brain, without significant changes in TSH levels.55
The relationship between urinary BPA concentrations and
serum thyroid hormones was evaluated in 1346 adults and 329
adolescents (older than 12-19 years) from the NHANES 2007
to 2008.56 In adults, an inverse relationship between urinary
BPA and total T4 and TSH was observed, supporting previous
reports concerning the association between BPA and altered
thyroid hormones.57
In conclusion, human exposure to BPA may be associated
with alterations in circulating thyroid hormone levels, as
demonstrated in cross-sectional studies. However, additional
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longitudinal studies to assess the effects of BPA exposure and
endocrine function, with an eye to clinical implications, are
needed.
Human BPA Exposure and Type 2 Diabetes Mellitus
Initially, the possible association of type 2 diabetes mellitus
and BPA was studied cross-sectionally, implying the tested
hypothesis that diabetes is concomitant, but not necessarily
consequent to BPA exposure.
Since 2003, various NHANES cohorts in the United States
have been studied repeatedly to confirm this hypothesis, but the
results have often been discrepant. Lang et al58 were the first to
report a positive association with self-reported diabetes, whose
odds were 1.4 per 1-standard deviation increment in urinary
BPA concentration in the 2003 to 2004 cohort: 1455 adult
participants older than 18 to 74 years. They further supported
their findings when they repeated the study on 1493 patients in
the 2005 to 2006 cohort. Note that in this cohort (2005 to 2006),
the association with diabetes did not reach significance, but the
pooled estimates of the 2003 to 2008 cohorts remained signif-
icant.59 The authors reported that in the second cohort, urinary
BPA was 30% lower, with a geometric mean value of 1.79
compared with the earlier mean of 2.49 ng mL1. The greater
range of the patients’ BPA exposure in the first NHANES cycle
could have influenced the detection of BPA association with
diabetes. It was argued that self-reported diabetes could under-
estimate the true prevalence of diabetes.60 This modality of
diabetes recognition could have subtracted statistical power
from the former investigations. Thus, in 2011 a new study
included a third cycle (2007-2008) in the analysis and defined
diabetes according to glycated hemoglobin (HbA1c) measure-
ments. Overall, urinary BPA and HbA1c were significantly
associated in 4389 adult participants, though when the analysis
was replicated within each of the 3 cycles, it was recognized
that it was the first NHANES cycle that drove the correlation.61
In the same year, another analysis62 was conducted in the same
3 cohorts using recent guidelines of the American Diabetes
Association (ADA)63 for diabetes criteria, that is, a serum glu-
cose greater than 126 mg dL1 after fasting for a minimum of 8
hours, a serum glucose greater than 200 mg dL1 for those who
fasted less than 8 hours before their NHANES visit, an HbA1c
value greater than 6.5% or self-reported current use of oral
hypoglycemic medication or insulin. Using the full spectrum
of the possibilities to diagnose diabetes, this study found that
there was a positive association between serum BPA levels and
diabetes mellitus in this nationally representative sample of US
adults. In subsequent stratified analyses, the observed associa-
tion was found to be present among both normal weight and
overweight/obese adults.
A strong objection to the validity of the previous analyses on
NHANES was raised by LaKind et al64 at the end of 2012.
They claimed that using scientifically and clinically supporta-
ble exclusion criteria and outcome definitions, they consis-
tently found no associations between urinary BPA and heart
disease or diabetes.64 They concluded that, in principle, it is
inappropriate to use cross-sectional data sets like NHANES to
draw such conclusions about short-lived environmental chemi-
cals and chronic, complex diseases.
The work of LaKind et al64 soon drew replies and com-
ments, ranging from acknowledgment of support from the
Polycarbonate/BPA Global Group of the American Chemistry
Council, thus possibly endangering scientific independence of
judgement in this delicate matter that is very susceptible to the
influence of relevant economical interests, to comprehensive
reviews supporting the methodological approaches of the for-
mer works challenged by these authors.65
The NHANES saga was finally enriched by Sabanayagam
et al whose study examined the association between urinary
BPA levels and prediabetes in 3516 participants from the 3
cycles between 2003 and 2008.66 Again, prediabetes was
defined according to ADA criteria (fasting glucose concentra-
tion 100-125 mg dL1 or 2-hour glucose concentration of 140
199 mg dL1 or an HbA1c value of 5.7%-6.4%). This work
associated BPA with prediabetes, more strongly for women and
obese patients. In summary, with the exception of one study, all
the investigators who evaluated the association of BPA and
diabetes or prediabetes in the NHANES cohorts between
2003 and 2008 found at least some evidence of positive
association.
The association of BPA and diabetes has drawn attention
also in nonwestern countries, where the current diabetes epi-
demic is of major concern. In a cross-sectional study from
China, there was no detection of a clear association between
urinary BPA concentrations and objective measures of
impaired glucose regulation, including type 2 diabetes mellitus.
The study, involving 3423 participants selected from 10 185
candidates, was a representation of normotolerant, impaired
glucose regulation, and diabetes subjects. Caution is raised
by the authors because the study did not assess diet or treatment
of existing diabetes.67 A cross-sectional study of 1210 middle-
aged Koreans failed to detect an association between self-
reported diabetes and urinary BPA.68 The BPA urinary con-
centrations in Korean patients were comparable to these in the
US samples; nonetheless, as noted above, the methodology to
assess diabetes may have underestimated its prevalence. More
recently, higher BPA exposure, reflected in higher urinary con-
centrations of BPA, was associated with diabetes in the Iran
general adult population in a small study of 119 cases of type 2
diabetes mellitus controlled with 120 nondiabetic partici-
pants.69 Finally, 2581 patients from the Thai National Health
Examination Survey (2009) were investigated for the associa-
tion between serum BPA concentrations and impaired fasting
glucose or diabetes, the latter being defined on the basis of
either fasting plasma glucose or a physician’s diagnosis. Serum
BPA concentrations were associated with diabetes and not with
impaired fasting glucose.70
Most studies were cross-sectional in nature, with an inherent
limitation in the possibility of detecting a temporal relationship
between exposure and subsequent clinical manifestations that
support a causal relationship. Indeed, only through longitudinal
studies could stronger evidence be found to support the theory
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that BPA exposure contributes to the development of diabetes,
and the first of such studies in this field was published only
recently.71 The study involves 2 cohorts of the Nurses Health
Study (NHS): one composed of postmenopausal women (aver-
age age 66 years—NHS1), the other of younger, pre-
menopausal women (average age 46 years—NHS2). From the
2 cohorts, the authors measured BPA and 8 major phthalate
metabolites among 971 incident type 2 diabetes mellitus case–
control pairs. Interestingly, a clear association was found
between BPA and incident diabetes in the premenopausal
women but not in the post-menopausal women. The authors
speculated that this difference in susceptibility to diabetes from
exposure to BPA, according to menopausal status, could be
explained according to the hypothesis that the BPA endocrine
interference of estrogen receptors of pancreatic b cells would
be enhanced in premenopausal women. Thus, the findings of
this first longitudinal study strengthen the idea that BPA expo-
sure could increase diabetes risk, despite the often discrepant
results from the many cross-sectional studies conducted
worldwide.
Association with insulin resistance. It could be that BPA contri-
butes to type 2 diabetes mellitus by increasing insulin resis-
tance. This led to a Korean study of 950 individuals living in
urban areas, and such an association was supported by the study
reporting a significant positive relationship of urinary BPA
with plasma glucose concentrations.72 In 2012, a large cross-
sectional study included 3390 adults aged 40 years or older in
China.33 After adjusting for BMI, waist circumference, smok-
ing, alcohol intake, education levels, systolic blood pressure,
high-density lipoprotein, low-density lipoprotein, total choles-
terol, triglycerides, highly sensitive C-reactive protein, alanine
transaminase, and g-glutamyl transferase, the fourth quartile of
urinary BPA concentration significantly increased the preva-
lence of insulin resistance by 37% compared with the first
quartile. Interestingly, this association was driven by the
normal-weight individuals rather than by the overweight ones,
suggesting that the effect of higher BMI may overwhelm that of
BPA on insulin resistance in participants with higher BMI.
More recently, in overweight or obese Ohio children aged 3
to 8 years, the BPA levels were associated with insulin resis-
tance,73 providing further evidence for the potentially diabeto-
genic effects of BPA starting at a young age.
Human BPA Exposure, Metabolic Syndrome
Components, and Coronary Disease Risk Factors
Among the many risk factors for coronary disease, there
appears to be strong evidence of an association between BPA
and hypertension. In their analysis of the first NHANES cycle
(2003-2004) Shankar et al74 found a positive association
between the increasing levels of urinary BPA of 1380 partici-
pants and hypertension, independent of confounding factors
such as age, gender, race/ethnicity, smoking, BMI, type 2 dia-
betes mellitus, and total cholesterol levels. The odds of blood
pressure-reducing medication use and/or blood pressures >140/
90 mm Hg increased by 1.50 between the extreme tertiles of
BPA exposure. The same positive association was found in 560
elderly citizens from Korea even though the odds of being
hypertensive significantly increased, more than doubled, only
in the individuals without previous history of hypertension.75
In 2014, the participants in NHANES 2003 to 2008 showed
increasing levels of urinary BPA positively associatedwithmeta-
bolic syndrome.76 In contrast, in the Prospective Investigation of
theVasculature in theUppsala Seniors study,weaker associations
were observed for coronary risk assessed by the Framingham
Risk Score together with circulating serum levels of BPA.77
Human BPA Exposure and CVD
The NHANES cohorts support much of the evidence for an
association of urinary BPA and coronary disease, as was found
in the earlier work on the 2003 to 2004 cohort58 and confirmed
in the subsequent work of Meltzer et al,59 though attenuated in
the 2005 to 2006 cohort. Peripheral artery disease was also
associated with urinary BPA in an analysis of 745 participants
from the 2003 to 2004 cycle of NHANES, with odds increased
by 2.69 between the extreme tertiles of exposure.78 Similar
findings were also found in a European investigation of 591
patients participating in The Metabonomics and Genomics in
Coronary Artery Disease (MaGiCAD) study.79 The BPA expo-
sure was higher in those with severe coronary artery stenoses
compared to those with no vessel disease.
The incidence of coronary disease after BPA exposure was
also studied prospectively in NHANES 2003 to 2006 partici-
pants during the 10 years of follow-up and showed trends sim-
ilar to previously reported cross-sectional findings in the more
highly exposed participants, providing stronger support for the
hypothesis of adverse cardiovascular effects of BPA
exposure.80
Human Food Exposure to BPA
Humans are continuously exposed to BPA due to its presence
in food and the environment. Foods, especially canned food,
are the predominant means of human exposure to BPA,81
which is a key component of the epoxy resins used in the
internal coating of cans to prevent direct contact between the
metal wall of the container and the food or beverage content,
and to protect cans from rusting and corrosion.82,83 However,
due to an incomplete polymerization process, significant
amounts of BPA residues in this coating can migrate from the
cans to the food and beverage contents.81
Heat treatment, storage conditions, and the presence of dam-
age are the principal factors influencing BPA migration. Good-
son et al84 filled empty epoxyphenolic coated cans with 4
different foods and a simulated food. After filling, the cans
were sealed and processed using the usual conditions (90 min-
utes at 121C or 30 minutes at 121C). To evaluate the effect of
damage on BPA migration, half the cans were dented and then
all the cans (damaged and undamaged) were stored at 5C,
20C, and 40C and analyzed at 1, 3, and 9 months. The authors
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found that 80% to 100% of the BPA present in the coating
migrated into the food during the sterilization process, this
level remaining unchanged for extended storage and damaged
cans. Instead, Errico et al85 found different results for canned
tomatoes: in this study, the cans were stored at 25C, 37C, and
45C and, in order to simulate poor preservation, some cans
were dented. This study showed that the BPA migration level
increased with increasing storage temperature (at 37C and
45C, the concentrations were about 3 to 10 times those mea-
sured at 25C) and the presence of damage increased the BPA
migration by more than 30% to 40%. The controversial results
of these 2 studies can be explained by the different time/tem-
perature conditions employed during the sterilization process.
In fact, the drastic heat process used by Goodson et al84 deter-
mined an almost total release of BPA from the internal coating
of the cans, therefore the subsequent storage and presence of
damage proved inconsequential. However, in the second
study,85 where the tomato products have a low pH, the sterili-
zation of the product was achieved under milder heat process-
ing conditions (generally 6 minutes at 115C). In this case, part
of the residual BPA remained in the coating after the steriliza-
tion process and, therefore, the BPA concentration in the food
increased during storage and in the presence of damage. These
findings are supported by the findings of Munguia-Lopez and
Soto-Valdez andMunguia-Lopez et al86-88 who also studied the
effect of heating on BPA migration in canned jalapen˜o peppers
and tuna fish. As jalapen˜o peppers have a lower pH than tuna
fish, the heat processing conditions required for product ster-
ilization were milder (9 minutes at 100C vs 90 minutes at
121C). The authors found that the migration of BPA in tuna
fish was high immediately after the sterilization process and
remained constant during 40 and 70 days of storage, while the
concentrations of BPA found in jalapen˜o peppers were very
low after the sterilization process and increased with storage
time. Finally, Kang et al89 reported that temperature influences
BPA migration from cans more than heating time in water
samples. Moreover, the can content also affects BPA migra-
tion. In fact, the presence of glucose, NaCl, or oil determines a
higher release of BPA from heated cans.89,90
Many worldwide studies have determined BPA concentra-
tion in canned food,82,83,90-98 and BPA has been detected in
59% to 100% of the analyzed samples.81 Table 1 shows the
mean values of BPA concentrations in canned food and bev-
erages from studies reported in the literature. Large between-
study differences in BPA concentration in the same foods are
reported. For example, BPA concentration in tuna fish ranges
between 9.8 ng g1 in Japan92 and 288 ng g1 in Turkey.90
Similarly, BPA in corn was found to be 22-fold more concen-
trated (7.2-175.7 ng g1) in cans purchased in Turkey90 than in
Korea.93 Beans were found to be contaminated by BPA in
concentrations ranging from not detectable amounts to 650.1
ng g1.90,91 At the same time, a large variation in BPA con-
centration was found in different samples of the same food
within the same study. Indeed, the study of Sungur at al90
reports beans with a BPA concentration ranging from 85.1 to
1858.7 ng g1 and Thomson and Grounds91 reports a
concentration in tuna fish of BPA between <20 and 109 ng
g1. Such variations are probably due to the different analytical
methods and sensitivities used for BPA determination, differ-
ent canned food manufacturer processing conditions, and the
different kinds of can and coating used. Given its low water
solubility, it has been suggested that BPA tends to favor parti-
tioning in the solid fraction rather than in the liquid when both
are present in the same can, especially for food items of high fat
content.94 This would explain the high BPA levels found in
tuna fish and other food items rich in fat, and also the level
found in beans, corn, and peas where no, or little, fat is present.
Bisphenol A was also found, though in lower concentra-
tions, in canned beverages.93,94,99-101 However, differently
from the canned food data, the data of the beverages were more
homogeneous in the different studies reported. Moreover, the
range of values of the individual BPA concentration studies of
the different samples of the same beverage was smaller than
that reported for canned foods. These lower values could be
explained by the milder sterilization conditions, the different
can types, and coatings used.81 However, it should be kept in
the mind that total BPA intake is the result of the amount
ingested and the consumption frequency of BPA contaminated
foods. Therefore, large amounts and/or frequently consumed
foods (like canned beverages) could contribute significant
quantities of BPA despite low BPA concentrations.
Epoxy resins are not only used as the internal coating of cans
but are also on the metal lids of glass jars. However, as the
contact between food and the lid is lower than that between
food and the internal surface of the can, the concentration of
BPA in these foods is lower. Studies have found a BPA con-
centration <1 ng g1 in the majority of analyzed samples
(70%), with an overall average concentration of 1.1 ng g1.81
Bisphenol A is also used in the production of polycarbonate
bottles and containers. Polycarbonates may release residual
BPA into the food by diffusion after the manufacturing process
and by hydrolysis of BPA polymers catalyzed by bases.102 The
principal factors influencing the release of BPA from polycar-
bonates are temperature, contact time, and pH of the liquid
food,103 but few studies are available on BPA release from
polycarbonate products.104 Hoekstra and Simoneau104 reported
BPA concentrations beneath the limit of detection in food or
food simulant. In fact, BPA was not detected in fruit juice, milk
formula,105 soup, steamed hot rice, or cooked hot pork.106
Polycarbonates are also used in the production of baby bottles.
Many studies focused their attention on the release of BPA
from these containers, revealing a BPA migration level ranging
between 0.3 and 521 mg L1.81 However, the highest releases
of BPA were found in bottles exposed to elevated temperature
and/or to long contact time conditions (eg, heating water at
70C for 6 days), unlikely conditions in real life.81 In fact,
De Coensel et al107 reported low BPA concentrations in these
food items (6-13 ng L1) under normal conditions.
Furthermore also fresh, daily consumed food has been
revealed to contain BPA; indeed, Cao et al82 found low BPA
levels (0.4-1.73 ng g1) in bread and cereal, vegetables, cheese
(0.68-2.24 ng g1), and in fast food composite samples
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(1.1-10.9 ng g1). The bread contamination may be explained
by the presence of BPA in the baking powder (0.64 ng g1) and
yeast (8.52 ng g1), which may have been contaminated by the
packaging used, such as packaging film in Polyvinyl chloride
(PVC) where BPA is used as an additive, or by contamination
during the production process.81 Furthermore, PVC film also
could be the origin of the cheese and fast food products con-
tamination. Finally, contamination of the vegetables could
have occurred during the packaging, transport, and manufac-
turing phases. Although the fresh food presented BPA concen-
trations lower than the canned food, its frequency of
consumption is much higher, so its contribution to BPA human
exposure may not be as negligible as previously thought.
Conclusion
Many of today’s cross-sectional studies support, sometimes
contradictorily, an adverse effect of BPA exposure on obesity,
type 2 diabetes mellitus, and CVD. However, few prospective
observational studies support an adverse effect of BPA expo-
sure on type 2 diabetes mellitus and CVDs.
No intervention studies have been conducted to evaluate the
causality of these associations to date. Indeed, this striking lack
of evidence is not casual, it is the result of the lack of knowl-
edge of food BPA content and, consequently, on the impossi-
bility of quantifying the daily dietary BPA intake. At best,
individual urinary or plasma samples could reflect a single
day’s BPA intake, but certainly not the customary and cumu-
lative BPA exposure over time. To provide an example: it
would be like trying to assess the effect of sodium intake on
the risk of hypertension by measuring a single-sample urinary
sodium concentration. For this reason, in our review, data
available on BPA food content has been provided. An inspec-
tion of such data strongly urges that further effort be made to
investigate the determinants of dietary BPA intake, in order to
provide databases that are detailed enough to quantify BPA
Table 1. BPA Mean Concentrations in Canned Food and Beverages.a
Food Item Mean (ng/g) Range Ref Food Item Mean (ng/g) Range Ref
Fish Pasta
Tuna fish 88.9 9.8-288 83,90-96 Ravioli 51.5 29.9-73.1 82,94,95
Salmon 10.6 3.4-13.7 83,92-94 Pasta 18.9 ND-32 83,91,95
Anchovy 0.9 94
Mackerel 25.7 ND-77.8 83,92,93,95 Soups and sauces
Saury 58.5 93 Vegetable soup 27.9 5-63 83,92,94,95
Mussel 11.0 93 Chicken soup 31.2 9.2-49.3 82,83,92,94,95
Crab 11.7 93 Fish soup 16.0 92
Smoked oyster 44.7 93 Cream 114.6 73.1-156 90,92
Sardines 20.0 83 Meat sauce 8.0 92
Brown sauce 605.7 92
Meat
Ham and Sausages 47.9 ND-117 83,93,94 Beverages
Chili 77.4 95 Cola 0.32 0.15-0.79 94,99-101
Canned meat 29.4 10.6-65.7 83,91-93 Energy drink 1.31 0.55-2.3 94,99,101
Beer 0.70 0.29-1.46 94,99,101
Fruit Sport drink 1.53 94
Fruit mix 12.1 ND-31.3 83,91,93,94 Iced tea 0.52 0.34-0.69 94,99
Peaches 10.8 ND-29.4 91-95 Apple juice 2.55 0.36-4.73 94,99
Pears 10.1 94 Orange juice 3.96 94
Pineapple 0.9 ND-3.2 82,91-93,95 Vegetable juice 0.88 94
Grape 4.2 ND-8.48 92,93 Tropical juice 1.93 94
Apricots ND 91 Soda drink 0.51 0.12-0.98 94,99,100
Tonic water 0.03 ND-0.06 94,99
Vegetables Sparkling water 0.00 94
Olives 13.6 8-21.4 91,92,94 Coffee 45.5 93
Carrots 26.0 25.9-26 83,94 Ginger ale 0.25 ND-0.49 99,100
Corn 46.0 7.2-175.7 83,90-95
Beans 113.4 ND-650.1 83,90-96 Infant formula
Peas 71.6 4.25-166.4 83,90,91,95 Liquid milk 4.42 2.75-5.53 82,97,98
Tomatoes 21.2 2.6-70 82,83,90-95 Liquid soy 5.89 5.75-6.03 97,98
Bamboo 14.0 ND-28 93,94 Concentrate milk 6.16 97
Mushrooms 45.4 ND-116.3 92-94 Concentrate soy 4.84 97
Beetroot 20.5 91 Powder milk ND 97
Asparagus 78.0 92 Powder soy ND 97
Abbreviations: BPA, bisphenol A; ND, not detectable amounts.
aBPA mean concentration range was reported when more than one value was available for the same food item.
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exposure in humans at both the individual and population level.
Such databases, which are currently lacking, would be instru-
mental to definitively clarifying the relationship between BPA,
obesity, and cardiometabolic risk.
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